BOLT (Bolt Biotherapeutics Inc.) Bozor qiymatining balans qiymatiga nisbati

boltbio.com (BOLT) kompaniyasining rasmiy ramzlari

Bolt Biotherapeutics (BOLT) kompaniyasining o'smalarga qarshi kurashdagi muvaffaqiyati ISAC-konjugatlarining xavfsizligiga bog'liq, biroq kutilmagan sinovlar va yuqori R&D xarajatlari sezilarli xatarlarni yuzaga keltirmoqda. 0.97 darajasiga yetgan ushbu kunlik narx harakati quyida tasvirlangan. Biznes himoyalangan patent portfeliga va yirik fondlarning qo'llab-quvvatlashiga tayanadi, bu esa immun tizimini kuchaytirishning innovatsion usullarini ishlab chiqish jarayonida moliyaviy barqarorlikni ta'minlaydi.

BOLT boltbio.com: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida

Bolt Biotherapeutics (BOLT) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari boltbio.com|BOLT - Tahlilchilarning prognoz narxlari
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Bolt Bio|BOLT - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Bolt Biotherapeutics|BOLT - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati boltbio.com|BOLT - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Bolt Biotherapeutics|BOLT - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati boltbio.com|BOLT - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Bolt Bio
Kompaniyaning dastlabki tahlili:Bolt Biotherapeutics Inc. - BOLT
boltbio.com original mahsuloti

Fundamental xatarlarni minimallashtirish sof aktivlardan yuqori premiumning qat'iy tahlilini talab qiladi. Ushbu koeffitsient umumiy bozor kapitalizatsiyasi va balans qiymati o'rtasidagi nisbat sifatida hisoblanadi va kapitalning bir birligi uchun xarajatni belgilaydi. Bolt Biotherapeutics (BOLT) uchun ushbu muvozanat Pfizer kompaniyasining R&D investitsiyalariga va FDA ning qat'iy xavfsizlik nazoratlariga bog'liq. Bolt Biotherapeutics (BOLT) ning joriy P/B koeffitsiyentini tahlil qilish orqali investor haddan tashqari yuqori baholash yoki biznes stagnatsiyasi xavfini aniqlashi mumkin.

Asosiy raqobatchilar

ARGX - Kapitallashuvning sof aktivlarga nisbati|BNTX (biontech.de) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|RIGL - Bozor kapitallashuvining balans qiymatiga nisbati|ANAB: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati ATXS|ENGN (engene.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati RAPT Therapeutics|Bozor qiymatining balans qiymatiga nisbati Aerovate (JBIO)|Kapitallashuvning sof aktivlarga nisbati Aclaris|Bozor kapitallashuvining balans qiymatiga multiplikatori Kyverna Therapeutics, Inc KYTX|Kapitallashuvning sof aktivlarga nisbati Tiziana Life Sciences|Balans qiymatiga nisbatan bozor qiymati cabalettabio.com CABA|VTYX - Bozor kapitallashuvining balans qiymatiga nisbati|THTX - Bozor qiymatining balans qiymatiga nisbati|Avalo Therapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|ELDN (Eledon Pharmaceuticals, Inc) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati AGEN (Agenus)|Bozor qiymatining balans qiymatiga koeffitsiyenti climbbio.com (CLYM)|Kapitallashuvning sof aktivlarga nisbati Zura Bio|Bozor kapitallashuvining balans qiymatiga multiplikatori aTyr Pharma Inc (ATYR)|Bozor kapitallashuvining balans qiymatiga nisbati Adagene Inc.|Balans qiymatiga nisbatan bozor qiymati ImageneBio IMA|STTK (Shattuck Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|EQ: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati connectbiopharm.com CNTB|Immunic (IMUX) - Balans qiymatiga nisbatan bozor qiymati|ATRA (Atara Biotherapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IFRX|XFOR - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi adicetbio.com (ACET)|CELU: Bozor kapitallashuvining balans qiymatiga nisbati|INMB - Bozor qiymatining balans qiymatiga koeffitsiyenti|Barinthus Bio - Kapitallashuvning sof aktivlarga nisbati|Kezar Life Sciences Inc (KZR) - Bozor kapitallashuvining balans qiymatiga nisbati|SABS - Kapitallashuvning sof aktivlarga nisbati|akaritx.com (AKTX) - Bozor kapitallashuvining balans qiymatiga multiplikatori|ENLV: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Q32 Bio Corp|Bozor kapitallashuvining balans qiymatiga nisbati GOVX (GeoVax Labs Inc)|Kapitallashuvning sof aktivlarga nisbati EDSA (Edesa Biotech Corp)|Bozor qiymatining balans qiymatiga nisbati IBIO|Balans qiymatiga nisbatan bozor kapitallashuvi Carisma Therapeutics Inc CARM|XTLB - Bozor kapitallashuvining balans qiymatiga nisbati|HCWB: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati APVO|AIM (aimimmuno.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc.|Bozor qiymatining balans qiymatiga nisbati gribio.com (GRI)|Kapitallashuvning sof aktivlarga nisbati XORTX Therapeutics|Bozor kapitallashuvining balans qiymatiga multiplikatori HIND (Vyome Holdings Inc.)|Revelation Bio (REVB) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Indaptus Corp INDP|Bozor kapitallashuvining balans qiymatiga nisbati Scinai Immunotherapeutics (SCNI)|CALI - Balans qiymatiga nisbatan bozor qiymati|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|ALLK (Allakos) - Bozor kapitallashuvining balans qiymatiga nisbati|HOOK - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IGMS|Bozor qiymatining balans qiymatiga nisbati ITOS (iTeos Therapeutics)|Kapitallashuvning sof aktivlarga nisbati oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|THRD - Bozor kapitallashuvining balans qiymatiga nisbati